About ANRI
ANRI is a venture capital firm founded in 2012. It is primarily based out of Tokyo, Japan. As of Mar 2026, ANRI is an active investor, having invested in 205 companies, with 10 new investments in the last 12 months. It primarily invests in Seed round in Japan based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Consumer and High Tech. Most recently it participated in the $***** Seed round of Grafto Overall, ANRI portfolio has seen 7 IPOs and 9 acquisitions including key companies like UPSIDER, Raksul and Aculys. A lot of funds co-invest with ANRI, with names like Mitsubishi UFJ Capital sharing a substantial percentage of its portfolio. ANRI has team of 18 people including 5 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 3 more
Portfolio Soonicorns
ANRI's List of Top Investments
ANRI has a portfolio of 205 companies. Their most notable investments are in Infobox and Matilda.Their portfolio spans across Japan, United States, France and 2 more locations. They have invested in Enterprise Applications, Consumer, High Tech and 32 other sectors, across stages such as Seed, Series A and 3 more. Here is the list of top investments by ANRI:1. Luup
App-based platform for electric kick scooters. Through the app, users can find and book electric kick scooters. Also, they can navigate to the nearby bike stations to get the scooters. Users can unlock the scooters by scanning the QR code. It offers station-based service users have to leave the scooter at the nearby docks at the end of the ride.
Key facts about Luup
- Founded Year: 2018
- Location: Shibuya (Japan)
- Stage: Series C
- Total Funding till date: $87.9M
- Employee Count: 83 as on Feb 28, 2026
- Investors: Mori Trust, ANRI and 24 Others
- Latest Funding Round: Conventional Debt, Oct 22, 2024, $*****
- Highlight: Editors' Pick
Provider of a platform to deliver mRNA therapeutics for multi-functional treatments. The programming platform detects the location and enhances the cell type protein expression in the patient's body to optimize the immunotherapy treatments.
Key facts about Strand Therapeutics
- Founded Year: 2017
- Location: Cambridge (United States)
- Stage: Series B
- Total Funding till date: $256M
- Employee Count: 119 as on Mar 31, 2026
- Investors: Kinnevik, Redmile Group and 19 Others
- Latest Funding Round: Series B, May 23, 2025, $*****
- Highlight: Editors' Pick
3. Gojo
Key facts about Gojo
- Founded Year: 2014
- Location: Shibuya (Japan)
- Stage: Series F
- Total Funding till date: $325M
- Employee Count: 69 as on Mar 31, 2026
- Investors: Baillie Gifford, GMO Venture Partners and 41 Others
- Latest Funding Round: Series F, Sep 2024, $*****
4. UPSIDER
Fintech company offering a corporate card solution for businesses. The platform provides corporate cards which allowing businesses to manage the finances with features such as cloud accounting, bookkeeping, invoice system, slack integration, card lock function, and more.
Key facts about UPSIDER
- Founded Year: 2018
- Location: Tokyo (Japan)
- Stage: Acquired
- Total Funding till date: $151M
- Employee Count: 88 as on Feb 28, 2026
- Investors: DST Global, Tencent and 12 Others
- Latest Funding Round: Series D, Nov 20, 2024, $*****
- Highlight: Acquired
5. Raksul
Raksul is online platform that connects clients with printing companies in Japan. It partners with different printing companies to provide printing directly from the website. Once the customer enters his printing needs, it has an algorithm to find them the best printer and price for their needs. From there, the printing company takes over and delivers the goods to the user.Charges a commission feed on every transaction. Claims to have 100,000 clients as of February 2015.
Key facts about Raksul
- Founded Year: 2009
- Location: Shinagawa (Japan)
- Stage: Public
- Total Funding till date: $71.1M
- Employee Count: 64 as on Oct 31, 2024
- Investors: Fidelity Investments, Global Catalyst Partners and 17 Others
- Latest Funding Round: Series D, Aug 04, 2016, $*****
- Highlight: Public
ANRI's Year-on-Year Investment Trends
ANRI has invested in 205 companies over the last 14 years, with an average of 11 new investments annually in the last 10 years. In 2025, it made 19 investments, while as of Mar 2026, it has made 7 investments in this year. Its most recent first time investment was in Grafto and most recent follow-on round was in Cosomil.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 6 | 1 | 7 |
2025 | 11 | 8 | 19 |
2024 | 11 | 11 | 22 |
2023 | 21 | 8 | 29 |
2022 | 21 | 5 | 26 |
2021 | 15 | 3 | 18 |
2020 | 4 | 2 | 6 |
2019 | 7 | 2 | 9 |
2018 | 11 | 2 | 13 |
2017 | 5 | 0 | 5 |
ANRI's Investments by Stage
ANRI has made 83 investments in Seed stage with an average round size of $2.39M, 30 investments in Series A stage with an average round size of $11M, 5 investments in Series B stage with an average round size of $10.2M, 2 investments in Series C stage with an average round size of $17.9M and 2 investments in Series D stage with an average round size of $31.3M.Stage of entry | No. of Investments |
|---|---|
Seed | 83 |
Series A | 30 |
Series B | 5 |
Series C | 2 |
Series D | 2 |
Note: We have considered here, only first round of investments
ANRI's Investments by Sector
ANRI has a diverse portfolio, with companies operating in the Enterprise Applications, Consumer, Business Services, High Tech and Life Sciences. Notably, it has invested in 126 Tech companies, 85 Enterprise (B2B) companies, 67 Software companies and at least 55 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 30 |
Consumer | 20 |
Business Services | 18 |
High Tech | 18 |
Life Sciences | 13 |
Others | 118 |
Note: We have considered here, only first round of investments
ANRI's Investments by Geography
ANRI has made most investments in Japan (119), followed by United States where it has made 3 investments.Country | No. of Investments |
|---|---|
Japan | 119 |
United States | 3 |
Note: We have considered here, only first round of investments
ANRI's recent investments
ANRI has made 7 investments in 2026 so far. Grafto and ReDeltah are the latest among them.Here are the most recent investments by ANRI:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Mar 17, 2026 | Japan | Seed | 3738 | [+1] | |
Mar 05, 2026 | Japan | Seed | 8810 | [+2] | |
Mar 05, 2026 | Japan | Seed | 7502 | [+1] | |
Feb 12, 2026 | Japan | Seed | 1557 | [+2] | |
Feb 06, 2026 | Japan | Series A | 8519 | [+3] |
IPOs and Publicly Listed companies in ANRI's Portfolio
7 of ANRI's portfolio companies have become public. Dely got listed on the Tokyo Stock Exchange (TSE), in Dec 2024 at marketcap of $314M and Sapeet got listed on the Tokyo Stock Exchange (TSE) at marketcap of $13.6M.Here are ANRI's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 19, 2024 | Sep 08, 2014 | Seed | 3553 | |
Oct 29, 2024 | 2016 | Seed | 1515 | |
Oct 22, 2024 | Oct 2012 | Seed | 9916 | |
Sep 25, 2024 | - | - | 7403 | |
Dec 15, 2022 | - | - | 5471 |
Acquired companies in ANRI's Portfolio
9 companies from ANRI's portfolio have been acquired. The most recent acquisition were Exroad in Mar 2026 by Asuene.Here are ANRI's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 17, 2026 | Jul 20, 2023 | Seed | 3731 | |
Oct 15, 2025 | Oct 29, 2021 | Series A | 4937 | |
Jul 29, 2025 | Nov 20, 2024 | Series D | 5555 | |
May 31, 2024 | - | - | 5014 | |
Jul 24, 2023 | - | - | 1127 |
Team profile of ANRI
ANRI has a team of 18 members including 5 Partners, 4 Venture Partners and 4 Principals located in Japan. ANRI's team does not sit on the board of any company as of now.Here is a list of top team members in ANRI:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Tokyo | - | - | |
Partner | Tokyo | - | ||
Partner | Japan | - | - | |
Partner | Shibuya | - | - | |
Partner | Tokyo | - | - | |
Venture Partner | Japan | - | - | |
Venture Partner | Japan | - | - | |
Venture Partner | Japan | - | - | |
Venture Partner | Kobe | - | - | |
Principal | Tokyo | - | - | |
Principal | Tokyo | - | - |
Co-investors of ANRI
Over the past 14 years, 564 investors have co-invested in ANRI's portfolio companies. This includes funds and angels.
- Invested before ANRI: Global Brain, TBS Innovation Partners and 44 others have invested in rounds before ANRI. There are 5 companies where Global Brain has invested before ANRI and 2 companies where TBS Innovation Partners has invested before ANRI.
- Top Co-investors of ANRI: 230 investors entered a company along with ANRI. These include investors like Mitsubishi UFJ Capital (9 companies).
- Invested after ANRI: A total of 288 investors have invested in ANRI's portfolio after their investments. Top Investors include Mitsubishi UFJ Capital (9 companies), SMBC Venture Capital (7 companies) and Globis Capital Partners (7 companies).
Recent News related to ANRI
•
Riddelta, provider of SE Asia-focused M&A database, raises 120M yenstartuplog.com•Mar 05, 2026•Luatsu, G-Startup Worldwide, ANRI, East Ventures
•
Tobosho raises funds in pre-Series A round - Mitsubishi UFJ Capital participatesTHE BRIDGE•Jan 15, 2026•MUFG Bank, NOW, GENDA, ANRI and 1 other
•
Couple app "Riamo" developer Sukidayo raises 85 million yen in seed roundstartuplog.com•Jan 14, 2026•Uneri, Sukidayo, Kayak, i-nest capital and 2 others
•
Tohakusha raises funds in pre-series A round; Mitsubishi UFJ Capital participatesExcite Japan•Jan 13, 2026•NOW, GENDA, ANRI, Mitsubishi UFJ Capital and 2 others
•
FerroptoCure Completes $6.5M Series A Funding to Advance Cancer TherapiesPR TIMES•Sep 19, 2025•Vision Incubate, FerroptoCure, Diamond Medino Capital, Tokyo University of Science and 2 others
•
Strand Therapeutics raises $153M for ‘programmable’ mRNA drugs; Regeneron, Eli Lilly, and Amgen back the firmBioPharmaDive•Aug 08, 2025•Strand Therapeutics, Lilly, Regeneron Pharmaceuticals, Kinnevik and 12 others
•
3DC Secures $24.5M in Series A, Starts GMS Mass Production PlantPR TIMES•Aug 04, 2025•3DC, NEDO, ANRI, Osaka University Venture Capital and 5 others
•
Y Combinator joins $22m series A for Japanese headless ERP startupTech in Asia•Jul 01, 2025•Tailor, ANRI, JIC Venture Growth Investments, New Enterprise Associates and 2 others
•
Tailor Secures $22M in Series A to Expand Headless ERP PlatformTechCrunch+•Jun 30, 2025•Tailor, ANRI, JIC Venture Growth Investments, New Enterprise Associates and 2 others
•
Tailor, a 'headless' ERP startup, raises $22M Series AYahoo•Jun 30, 2025•Tailor, ANRI, JIC Venture Growth Investments, New Enterprise Associates and 2 others
